530 results about "Treatment protocol" patented technology

The present invention provides automated peritoneal dialysis systems, methods of operating the systems and devices for performing same. A typical therapy performed by the present invention begins by draining dialysis solution that is already in the patient's peritoneal cavity. The system pumps fresh dialysate from one of a plurality of supply bags, through an in-line heater to the patient's peritoneal cavity. After a dwell period, the spent dialysate in the cavity is pumped out of the patient to a drain or other disposal means. The system then pumps fresh dialysate from the supply bags to the patient and the procedure is repeated as defined in the therapy protocol. The system can pump a last bag of dialysate to the peritoneal cavity for an extended dwell, such as a daytime dwell.

A photon therapy unit implement has a flexible head for conforming to a body part to be treated. The head has a thermally conductive backing to remove heat form the treatment area. The operation of the head is monitored by a photon detector to provide a feedback to the diode drive circuit to maintain the output at the required level. Operation of the head is monitored by a microprocessor which performs a diagnostic function and reports on defects. The treatment protocol is generated by a main control unit that formulates a treatment waveform from a set of treatment protocols. The selection of protocols is performed through a graphical user interface (GUI) which allows selection of treatment areas and customization of treatment as well as maintaining patient history and annotations.

A thin film electroluminescent (TFEL) phototherapy device based on high field electroluminescence (HFEL) or from organic light emitting devices (OLED), consistent with certain embodiments of the present invention has a battery and a charging circuit coupled to the battery, so that when connected to a source of current acts to charge the battery. A TFEL panel produces light when voltage from the power source (battery or AC source) is applied. A processor such as a microprocessor is used to control the application of voltage from the power source to the TFEL panel under control of a control program. A housing is used to contain the battery, the charging circuit and the processor and carry the TFEL panel on an outer surface thereof. In one embodiment, the housing incorporates a removable cover that uncovers a household electrical plug useful for supplying charging current to the charger. In use, a method of carrying out phototherapy, consistent with certain embodiments of the invention involves diagnosing a condition of an affected area of tissue that can be treated with phototherapy. A treatment protocol is determined including, for example, a treatment light intensity, a treatment time, a light modulation characteristic and a treatment light wavelength suitable for treating the condition. The affected area is then irradiated with light from the TFEL panel in accord with the treatment protocol.

An online occupational medicine management system and method that allow authorized physicians, patients, employers, and insurance companies to capture, store, retrieve, and disseminate an employee's medical records from any computer having Internet access. The employee medical information can be shared between the aforementioned parties in real time, resulting in improved quality of care and greater efficiency in the field of work-related injuries, i.e., workers' compensation. The online occupational medicine management system also provides physicians with diagnosis appropriate treatment protocols that can be pre-approved by a patient's employer and / or the employer's insurance company, thus requiring monitoring only of medical treatments that fall outside of the pre-approved protocols. Accordingly, administrative costs to insurance companies and employers are lessened, and payment time to physicians is reduced.

A vascular access device and method of using is disclosed. The vascular access device includes a housing defining a cavity and adapted to connect to a catheter. A self-sealing injection port and a subhousing are also provided. The subhousing may be movably connected to the housing so that a position of the other end of the subhousing relative to the housing can be selectively adjusted within a range of positions. A unidirectional fluid valve permits solution flow from the subhousing to the housing. The vascular access device may be utilized in a variety of treatment protocols including medication administration, fluid sampling, and placement of balloon catheters or guide wire-based medical devices.

A porous implant system includes a gradient source adapted for transferring a gradient to an interface connected to an implant at a patient situs. The gradient source is controlled by a programmable controller. The implant is bonded to the patient by tissue ingrowth, which is facilitated by the gradient formed across the porous portion of the implant. A treatment method and includes the steps of providing a porous implant, connecting same to a gradient source through an interface, forming a gradient across the implant and controlling the operation of the gradient source according to a predetermined and preprogrammed treatment protocol.

A systems biology approach is used to characterize and relate the intestinal (gut) microbiome of a host organism (e.g. a human) to physiological processes within the host. Information regarding the types and relative amounts of gut microflora is correlated with physiological processes indicative of e.g., a patient's risk of developing a disease or condition, likelihood of responding to a particular treatment, for adjusting treatment protocols, etc. The information is also used to identify novel suitable therapeutic targets and / or to develop and monitor the outcome of therapeutic treatments. An exemplary disease / condition is the development of hepatic encephalopathy (HE), particularly in patients with liver cirrhosis.

A system, method, and computer program product for interactively defining and calibrating a treatment protocol program for a stimulation device such as an implantable pulse generator (IPG). An IPG, whether it is a self-contained implantable pulse generator (SCIPG) or externally-powered implantable pulse generator (EPIPG), communicates with an external patient programmer (EPP) to receive treatment protocol programs. Using the EPP, treatment protocol programs are developed, executed, and tested while the patient provides real-time feedback, providing efficient and effective programming.

The invention relates to apparatus and method for ultrasonically stimulating cartilage growth. The apparatus includes at least one ergonomically constructed ultrasonic transducer configured to cooperate with a placement module or strip for placement in proximity to an area where cartilage growth is desired. The apparatus also utilizes a portable, ergonomically constructed main operating unit constructed to fit within a pouch worn by the patient. In operation, at least one ultrasonic transducer positioned in proximity to an osteochondral site is excited for a predetermined period of time. To ensure that at least one ultrasonic transducer is properly positioned, and to insure compliance with a treatment protocol, a safety interlock is provided to prevent inadvertent excitation of the at least one ultrasonic transducer.

A system and method for disease management that effectively eliminates unnecessary layers and / or intermediaries within the healthcare management system by enabling a disease management entity to operate as an extension of a physician's office, and thus, work closely with the patients and the patient's physicians to effectively empower patients towards self-care and a higher level of awareness and understanding of their disease process and treatment. The present system and method utilizes a team of highly trained healthcare professionals and technicians working together with patients and physicians, wherein remote vital sign monitoring equipment, software systems, and standing orders and treatment protocols, are utilized to effectively manage patients with chronic conditions. Additionally, as the disease management entity operates as an extension of a physician's office, the disease management entity is able to coordinate with a payor through the physician's office, and thus provide the payor with positive financial outcomes.

A System manages IV pumps so that clinicians automatically receive alerts, decisions, and actions required to maintain a patient IV medication therapy according to a prescribed treatment protocol. An infusion pump monitoring system, includes an acquisition processor for acquiring fluid infusion parameters comprising a patient identifier, infusion fluid identifier and a rate of fluid infusion, for administration of an infusion fluid to a patient at a point of care using an infusion pump. The system also includes a repository of patient medical record information. A fluid infusion monitor uses acquired fluid infusion parameters for automatically searching a patient medical record in the repository for information concerning rate of fluid infusion of a particular infusion fluid and determining if a rate of a previously administered dose of the particular infusion fluid was lower than a rate indicated in the fluid infusion parameters. An interface processor automatically initiates generation of a message indicating a potential adverse reaction to the particular infusion fluid in response to a determination of a lower rate being employed for previously administering the particular infusion fluid.

An apparatus provides automatically controlled facial rejuvenation treatments and is comprised of a scanner for scanning a patient's face, a treatment robot, including a plurality of dermatological devices for treatment of facial skin, and a computer coupled to the scanner and robot for determining a treatment protocol of the patient's face based on a scanned input of the patient's face and for generating a plurality of commands for the treatment robot for movement and / or control of the plurality of dermatological devices for the automated treatment of the skin of the patient's face. A dermatological laser, needle injector, and / or air injector are used. The needle injector injects a minute amount of substance at a multiplicity of points within a computer-identified treatment area on the patient's face.

The present specification discloses systems and methods for patient monitoring using a multitude of display regions, at least two of which have the capability to simultaneously display real time patient waveforms and vital statistics as well as provide display for local and remote software applications. In one example, a primary display shows real time patient waveforms and vital statistics while a customizable secondary display shows trends, cumulative data, laboratory and radiology reports, protocols, and similar clinical information. Additionally, the secondary display can launch local and remote applications such as entertainment software, Internet and email programs, patient education software, and video conferencing applications. The dual display allows caregivers to simultaneously view real time patient vitals and aggregated data or therapy protocols, thereby increasing hospital personnel efficiency and improving treatment, while not compromising the display of critical alarms or other data.

Methods and apparatus are provided for determining a defibrillation treatment protocol in an external defibrillator using a measurement of elapsed time. The present invention provides a defibrillator with a timer function. Upon activation of the defibrillator, an internal timer begins to run. By closely associating the activation of the defibrillator with the onset of the patient's attack, and by making allowances for inherent time differences between these events, the timer provides a measure of the elapsed time between the onset of the patient's emergency and the presentation of the defibrillator at the patient's side. Using this measure of elapsed time, the defibrillator determines an appropriate treatment therapy, such as CPR or defibrillation therapy.

A system for remote ischemic preconditioning that includes a cuff, and actuator, and a controller that operates the actuator according to a treatment protocol. The treatment protocol includes a plurality of treatment cycles that each comprise cuff actuation, an ischemic duration, cuff release, and a reperfusion duration.

A generic treatment protocol is disclosed for therapeutically treating a patient via an implantable treatment device. Treatment steps can be defined to start and end at absolute times, or can be programmed via telemetry to start a certain amount of time after termination of a previously executed treatment step. Treatment steps have a treatment rate or dose attribute and a duration attribute. Treatment steps may optionally enable patient-activated bolus overlays. Patient-activated rate or dosage adjustments can also optionally be enabled. Repeated-execution treatment-step groups are also provided. Such treatment-step groups can have start and end times, a group duration, and a group total dose, each defined in a manner similar to that for a treatment step. Treatment-step groups include a repetition count, which could be set to a value that causes the group to repeat forever. Single execution treatment steps can, accordingly, be programmed to execute before and / or after a repeated-execution treatment-step group.

A compliance / adherence management and automated data collection system uses a plurality of communications modalities implemented over wireless or wired communications systems for redundantly and persistently transmitting messages to and / or receiving messages from an end user for managing compliance / adherence of the end user concerning schedules and medication and treatment protocols. The system also uses wireless or wired communications modalities for automating real time collection of information from the end user concerning, for example, compliance with the schedule and / or protocol. The collected data can be remotely accessed, in real time, to monitor compliance / adherence and an end user's experiences resulting from compliance / adherence. Further, the management messages are so designed as to be highly personalized in order to achieve a more favorable response from the end user.

A method for dispensing alternative prescription products to a patient to provide the patient alternative treatment options and increase treatment protocol compliance. After a patient is diagnosed with a medical condition requiring treatment with a prescription product, the patient is provided with a kit containing a multiple continuous positive airway CPAP interfaces designed to adapt to a plurality of different facial features. Instead of being custom fitted by a CPAP interface specialist, the patient is given multiple CPAP interfaces to try and select the CPAP interface most desirable to the patient. The patient indicates the most desirable CPAP interface and, after a predetermined period of time, the patient is provided with a new CPAP interface matching the most desirable CPAP interface selected by the patient.

To achieve “ecological” robotic rehabilitation therapy, the present invention provides the system capacity of training of patients in different ambulatory tasks utilizing motorized footplates that guide the lower limbs according to human gait trajectories generated for different ambulatory tasks of interest. A lower extremity robotic rehabilitation system comprises an active pelvic / hip device which applies series elastic actuation to achieve an intrinsically safe and desirable impedance control. A robotic unit features the telepresence operation control that allows a patient stay at home or nursing home to continue his or her rehabilitation training under a physician's remote supervision and monitoring. The robot unit utilizes an affective patient-robot interface to capture emotional information of the patient, to allow for real-time adaptation of the robotic system and adjustments of treatment protocol, and to enhance the quality and effectiveness of rehabilitation

Aspects include methods and apparatuses for effecting change over time in one or more measured regions of a body using a plurality of data sets obtained by analysis of applied signals to said region and effecting a change in treatment protocol. The method may include transmitting and receiving one or more of electromagnetic wave signals, applied acoustic wave signals and electrical signals transmitted through or reflected off of a portion of the measured body region. Some aspects may include determining a change in tissue structure, or a change in tissue content.

A method of objectively quantifying assessments of joints having arthritis for purposes of assessment, diagnosis and treatment. The objective measurements utilize known imaging modalities including 3D scanning, thermal imaging, visible and near-infrared imaging and two-dimensional imaging to quantify swelling, heat distribution, erythema, and range or motion. The objective measurements can be combined in various ways to assess the extent of the disease and can be used to adjust treatment protocols.

Methods and systems for reducing compensation of the body to therapy delivered by an implanted medical device are described herein. The disclosed techniques cause a change from one therapy protocol to another therapy protocol based on the occurrence of an event (e.g., time, user activations of a sensor, input from a physiological sensor, etc.). The therapy protocols of the implanted medical device differ in terms of the on-time and off-time, but effectuate the same or similar duty cycle.

A method for treating a target tissue in a patient in need thereof is provided. The method includes the steps of identifying one or more characteristics of one or more cells of a target tissue; calculating a threshold electric field for inducing IRE in the target tissue based on the one or more characteristics; constructing a treatment protocol of one or more pulse parameters, wherein the treatment protocol is capable of inducing IRE in the target tissue; and delivering the treatment protocol to the target tissue. Systems for treatment planning for medical therapies involving administering electrical treatment energy are also provided.

The endometriosis treatment protocol provides for administering to a female patient in need of treatment for endometriosis a pharmaceutical composition in a form suitable for vaginal or rectal delivery having a pharmaceutically effective amount of an aromatase inhibitor, which may be either a steroid or non-steroidal. The pharmaceutical composition may be formed as a vaginal suppository, a rectal suppository, a vaginal gel, a rectal gel, a vaginal cream or a rectal cream. The pharmaceutical composition may optionally have pharmaceutically effective amounts of progesterone and calcitriol, and may be administered in combination with an oral COX-2 inhibitor. Alternatively, the pharmaceutical composition comprises an aromatase inhibitor administered vaginally or rectally and is administered in combination with oral calcitriol and the oral COX-2 inhibitor. The aromatase inhibitor is either steroidal or non-steroidal.

A system and method for treatment of neurological disorders with sound therapy is disclosed. The system can have a local PDA, a remote server, a physician's PC, and a database connected to the server. The PDA and PC can be networked with the server. The PC can initialize a treatment protocol stored at the server. The server can utilize the database and the protocol from the PC to come up with a recommended therapy. The recommended therapy can be selected by the PC and sent to the PDA. The PDA can then execute the selected therapy on the patient. The PDA can also record biometric and other feedback and send it to the server.

The subject invention is directed to new and useful neurostimulation systems that include an implantable pulse generator dimensioned and configured for implantation in the skull of a patient. The implantable pulse generator has an electrode operatively associated with a distal end portion thereof and can be provided with adjustment means, such as an adjustable biasing member or spring arranged between the electrode to the distal end portion of the pulse generator. The subject invention is also directed to systems involving networked neurostimulators that are configured and adapted to work jointly in accordance with prescribed treatment protocol to effect a desired recovery from brain injury. Such networked neurostimulation systems are particularly advantageous for effecting relatively large and / or relatively distant regions of the brain. The subject invention is further directed to systems and methods for motor-evoked potential (MEP)-based neuromodulation. Further, AC and / or DC stimulation can be utilized, depending on the precise implementation.

Removing malware from a computer system. An inspection module obtains an inspection log representing operational history of the operating system and the application programs of the computer system. The inspection log is analyzed to detect a presence of any malware on the computer system. A treatment scenario is generated that defines a plurality of actions to be executed for removing any malware present on the computer system, as detected in the analyzing. The treatment scenario is generated based on the information contained in the inspection log and on a knowledge base of malware removal rules. The generated treatment scenario is evaluated to assess the actions defined in the generated treatment scenario that are associated with a risk of damaging the operating system or the application programs of the computer system. A modified treatment scenario can be created to reduce the risk in response to an assessment of the risk.

Device for the controlled administration of substances to be inserted in a body cavity, characterized by: an anchoring medium allowing for a firm anchorage of the device in said body cavity; at least one substance support medium for the release of at least one substance into the body cavity following a specific protocol and in which each substance to be administered comprises an independent protocol that establishes a release kinetics with one or more substance administration stages, being each stage defined by a different release kinetics. These devices are useful to develop a simple or complex treatment protocol in mammals. The formulations applicable to the substance support media as well as the appropriate manufacturing processes are also provided.

A photon therapy unit implement has a flexible head for conforming to a body part to be treated. The head has a thermally conductive backing to remove heat from the treatment area. The operation of the head is monitored by a photon detector to provide a feedback to the diode drive circuit to maintain the output at the required level. Operation of the head is monitored by a microprocessor which performs a diagnostic function and reports on defects. The treatment protocol is generated by a main control unit that formulates a treatment waveform from a set of treatment protocols. The selection of protocols is performed through a graphical user interface (GUI) which allows selection of treatment areas and customization of treatment as well as maintaining patient history and annotations.